Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Eur J Surg ; 166(7): 572-6, 2000 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10965838

RESUMEN

OBJECTIVE: To investigate the incidence of adhesions after intraperitoneal instillation of mitomycin C adsorbed on activated carbon (MMC-CH). DESIGN: Animal and laboratory studies. SETTING: University hospital, Germany. ANIMALS: 90 Sprague-Dawley rats. INTERVENTIONS: Laparotomy, small bowel anastomosis, and intraperitoneal instillation of saline (controls, n = 27), activated carbon alone (n = 24) or MMC-CH (n = 26). Cultures of monolayers of human mesothelial cells. MAIN OUTCOME MEASURES: Measurements of adhesions by planimetry. Toxicity of mitomycin C alone and charcoal alone in mesothelial cell monolayers as reflected by cell proliferation and measurement of lactate dehydrogenase activity. Concentrations of plasminogen activator (tPA) and plasminogen activator inhibitor 1 (PAI-1) as measures of the fibrinolytic activity of mesothelial cells. RESULTS: Both activated carbon and MMC-CH caused a significant increase of adhesion formation in rats. Activated carbon also reduced the fibrinolytic activity of mesothelial cells, and mitomycin C caused concentration-dependent cytotoxicity in vitro. CONCLUSIONS: Activated carbon combined with high concentrations of mitomycin C may cause intraperitoneal infective complications by increasing the rate of adhesion formation and reducing the fibrinolytic activity of mesothelial cells. We recommend a new absorbable carrier for intraperitoneal chemotherapy.


Asunto(s)
Carbón Orgánico/efectos adversos , Células Epiteliales/efectos de los fármacos , Fibrinólisis/efectos de los fármacos , Mitomicina/efectos adversos , Neoplasias Gástricas/tratamiento farmacológico , Adherencias Tisulares/etiología , Animales , Carbón Orgánico/uso terapéutico , Modelos Animales de Enfermedad , Humanos , Técnicas In Vitro , Inyecciones Intraperitoneales , L-Lactato Deshidrogenasa/metabolismo , Mitomicina/uso terapéutico , Inhibidor 1 de Activador Plasminogénico/sangre , Ratas , Ratas Sprague-Dawley , Recurrencia , Análisis de Supervivencia , Activador de Tejido Plasminógeno/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA